Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome

This study investigated the specific neuroendocrine effects of acupuncture in patients with irritable bowel syndrome (IBS), a functional gastrointestinal disorder that markedly affects quality of life. Earlier work had shown that both true and placebo acupuncture improved IBS symptoms, raising questions about the specific mechanisms of acupuncture. The investigators conducted a randomized, placebo-controlled clinical trial in 43 patients diagnosed with IBS by Rome II criteria. Participants were randomly assigned to two groups: one received traditional acupuncture at 15 specific points (LR-3, ST-36, SP-6, CV-12, ST-21, ST-25, HT-7, GV-20), while the other received sham acupuncture using the Streitberger needle, which simulates the procedure without penetrating the skin.

Treatment consisted of 10 sessions delivered twice weekly over five weeks. To evaluate effects on the autonomic and neuroendocrine systems, the investigators used multiple objective measures. Salivary cortisol was collected at four time points (7 a.m., 12 p.m., 5 p.m., and 10 p.m.) before and after treatment to assess hypothalamic-pituitary-adrenal (HPA) axis function. Autonomic function was evaluated with tilt-table testing, including heart rate and blood pressure measurements at rest and during orthostatic stress.

Quality of life was assessed with validated questionnaires (FDDQL and SF-36). Results showed important between-group differences despite both arms demonstrating clinical improvement. Both groups had significant improvement in quality of life (p = 0.001) with no statistical difference between them, confirming earlier observations of the strong placebo effect of acupuncture. However, deeper analyses revealed physiologic effects specific to true acupuncture.

Salivary cortisol decreased in both groups, but the reduction was significantly greater in the true acupuncture group (p = 0.033), suggesting specific modulation of the stress axis. The effect on the autonomic nervous system was even more striking. During orthostatic stress testing, the true acupuncture group showed a blunted cardiac response, indicating increased parasympathetic tone, whereas the sham group maintained or increased their stress response (p = 0.005). This specific parasympathetic modulation correlated positively with pain improvement in the true acupuncture group (p = 0.006) but not in the placebo group.

The clinical implications are significant. IBS frequently involves HPA axis dysregulation and autonomic dysfunction, with sympathetic overactivity and elevated cortisol. The fact that real acupuncture produced specific changes in these systems suggests unique mechanisms of action distinct from placebo. Increased parasympathetic tone may contribute to regulation of intestinal motility and reduction of visceral hypersensitivity, both central to IBS pathophysiology.

The more pronounced cortisol reduction in the true acupuncture group indicates specific modulation of the stress response, which may explain part of the observed therapeutic benefit. The study has important limitations. The sample size was relatively small for subgroup analyses, particularly because only 21 patients had complete data for all measures. Some patients were excluded because of medications that could interfere with autonomic measures, limiting generalizability.

In addition, the wide individual variability in autonomic measures may affect the validity of conclusions in small samples. Despite these limitations, this is the first randomized controlled trial to demonstrate specific autonomic effects of acupuncture in patients with IBS. The findings suggest that, although placebo effects are powerful and clinically relevant, true acupuncture operates through specific physiologic mechanisms that may complement or potentiate the nonspecific effects of treatment.